Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Izabela
Izabela Fokt, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100022466 | THERMALLY-TARGETED DELIVERY OF MEDICAMENTS INCLUDING DOXORUBICIN - Elastin-like polypeptide (ELP) serves as a vector for thermally-targeted delivery of therapeutics, including cytotoxic chemotherapeutic drugs such as doxorubicin. Examples of an ELP-based delivery vehicle can comprise: (1) a cell penetrating peptide, such as a Tat protein, (2) ELP, and (3) the lysosomally degradable glycylphenylalanylleucylglycine (GFLG) spacer and a cysteine residue conjugated to therapeutic such as doxorubicin, or a analog thereof. | 01-28-2010 |
| 20100130434 | Hexose Compounds to Treat Cancer - Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a hexose compound to a subject in need thereof The subject invention includes methods of treating brain and pancreatic cancer comprising the administration of a therapeutically effective amount of a mannose compound to a subject in need thereof The subject invention further includes methods of treating the proliferation of tumors comprising the administration of a therapeutically effective amount of 2-FM to a subject in need thereof. | 05-27-2010 |
| 20100144802 | Small Molecule Inhibitors for Immune Modulation - Methods of treating immunosuppression by administering a therapeutic amount of a tryphostin compound of the formula: | 06-10-2010 |
| 20100152121 | Iodo-Hexose Compounds Useful to Treat Cancer - Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a iodo-hexose compound to a subject in need thereof. The subject disclosure includes methods of treating glioblastoma and pancreatic cancer comprising the administration of a therapeutically effective amount of a 2-deoxy-2-iodo-D-hexose compound including 2-deoxy-2-iodo-D-mannose, 2-deoxy-2-iodo-D-glucose, 2-deoxy-2-iodo-D-galactose, and/or 2-deoxy-2-iodo-D-talose to a subject in need thereof. | 06-17-2010 |
| 20110003758 | Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors - Provided herein are methods of treating brain tumors by administering a therapeutically effective amount of a compound of the Formulas I or II to a patient in need thereof. | 01-06-2011 |
| 20110021805 | COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES - The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines. | 01-27-2011 |
| 20110053992 | Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS) - Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders. | 03-03-2011 |
| 20110160151 | Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity - Novel compounds and methods of using the same to inhibit glycolysis and treat cancer and other diseases are provided herein. | 06-30-2011 |
Izabela Galeska, Pennington, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080306138 | STABLE NON-AQUEOUS POUR-ON COMPOSITIONS - The present invention relates to a stable, antiparasitic, non-aqueous pour-on parasiticidal composition which comprises an effective amount of amitraz, optionally a macrocyclic lactone, a stabilizer and a carrier system having no active hydroxyl group. | 12-11-2008 |
Izabela Grasland, Breteil FR
| Patent application number | Description | Published |
|---|---|---|
| 20080288438 | Device and Method for Multimedia Data Retrieval - The invention concerns a device for multimedia data retrieval, said multimedia data being associated with an active component, said device being characterized in that, depending on an external event, some of the active components trigger an action that make the user aware of the multimedia data associated with said active components. | 11-20-2008 |
| 20100135288 | AUTOMATIC COMPENSATION OF A DELAY OF A SYNCHRONIZATION SIGNAL IN A PACKET SWITCHING NETWORK - The present invention relates to a sending device able to send packets in a network comprising at least two stations, the said device comprising means for extracting image pips on the basis of a synchronization signal, initializing an image counter on the basis of the image pips, initializing a counter every “m” zero-crossings of the image counter, the counter being regulated by a clock produced by the image counter, sampling the counter every period T | 06-03-2010 |
Izabela Janowska, Strasbourg FR
| Patent application number | Description | Published |
|---|---|---|
| 20110262312 | PHOTOCATALYSTS BASED ON STRUCTURED THREE-DIMENSIONAL CARBIDE, IN PARTICULAR B-SIC, FOAMS - The invention relates to a photocatalyst comprising a β-SiC cellular foam and a photocatalytically active phase, deposited directly on said cellular foam or on an intermediate phase deposited on said cellular foam. The average size of the cells is between 2500 μm and 5000 μm. The foam can comprise nanotubes or nanofibers (particularly of carbon, SiC, and TiO | 10-27-2011 |
Izabela Koscielny, West Bloomfield, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20080287840 | NEUROLOGICAL MOTOR THERAPY SUIT - A neurological motor therapy suit includes a vest which is snugly, but removably, secured around the shoulders and chest of a patient. The vest completely encircles a portion of the upper torso of the patient and is constructed of a substantially non-elastic material. A pant garment is detachably secured to the patient so that the pant garment extends around both the hips of the patient as well as the upper portion of each thigh. The pant garment is also constructed of a substantially non-elastic material. A plurality of the elastic bands extend between and interconnect the vest and the pant garment. An elbow support is removably secured to the patient's elbow while a hand support is removably secured to the patient's hand. Both the elbow support and hand support include a plurality of hooks so that elastic bands detachably secure the hooks on the elbow support and hand support together as well as between the vest and the elbow support. | 11-20-2008 |
Izabela Sibilska, Warsaw PL
| Patent application number | Description | Published |
|---|---|---|
| 20110082121 | 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 1-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-1-desoxy-2-methylene-19-nor-vitamin D | 04-07-2011 |
Izabela Tworowska, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090087377 | COMPOSITIONS FOR TARGETED IMAGING AND THERAPY - The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging. | 04-02-2009 |
| 20100316566 | RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY - The present invention concerns methods and compositions related to a chelator and a HHRT ligand. In specific embodiments of the invention the chelator is conjugated to the HHRT ligand. In another specific embodiment of the invention, the chelator is chelated to a metal. In a particular embodiment of the invention, there is a metal species that is chelated to a chelator, which is then directly or indirectly conjugated to a HHRT ligand. In some embodiments, the composition further comprises a therapeutic agent. In particular cases, the compositions are employed for cancer diagnosis and/or therapy. | 12-16-2010 |